Breadcrumb

[A16-74] Palbociclib (breast cancer) - Benefit assessment according to §35a Social Code Book V

Overview

Overview

Commission: Commission awarded on 2016-11-23 by the Federal Joint Committee (G-BA)
Status:Commission completed
Department/Division:Drug Assessment
Current document:PDF Extract of dossier assessment  [PDF, 408 kB]Further documents
Note:

After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.

Contact address:to the contact form
Linked projects: [A18-63] Palbociclib (breast cancer) - Benefit assessment according to §35a Social Code Book V (expiry of the decision)
Status: Commission completed

[A17-15] Palbociclib (breast cancer) - Addendum to commission A16-74
Status: Commission completed


Report documents

Report documents

PublishedDocumentSizeType 
2017-03-01 Extract of dossier assessment 408 kBPDFdownload file
2017-03-01 Dossier assessment (German version) 2 MBPDFdownload file

After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.


At a glance

Accompanying information

Extract of dossier assessment

  File-Icon  Palbociclib (breast cancer) - Benefit assessment according to §35a Social Code Book V [PDF, 408 kB]

Federal Joint Committee (G-BA)

2017-05-18 A G-BA decision was published.

G-BA documents on this decision

Press releases

2017-03-01 Palbociclib in advanced breast cancer: Disadvantages predominate in certain patients



Save result list

To save your search result, please copy the link below and paste it into a new tab/window.

close